Cost-Effectiveness of Pembrolizumab as an Adjuvant Treatment in Colombia for Melanoma Patients with Lymph Node Involvement After Complete ResectionADVANCES IN THERAPYIF42023-05-023OAAI
Spurious alternative impact factors: The scale of the problem from an academic perspectiveBIOESSAYSIF2.72015-03-0261PREAI
Current status of Chagas disease chemotherapyEXPERT REVIEW OF ANTI-INFECTIVE THERAPYIF3.82014-01-10102PREAI
Congenital Chagas disease: time to screen pregnant women?EXPERT REVIEW OF ANTI-INFECTIVE THERAPYIF3.82014-01-107PREAI
Apoptosis-Associated Speck-like Protein Containing a Caspase Recruitment Domain Inflammasomes Mediate IL-1β Response and Host Resistance to Trypanosoma cruzi InfectionJOURNAL OF IMMUNOLOGYIF3.42013-09-1579OA
Prevalence of Trypanosoma cruzi Infection among People Aged 15 to 89 Years Inhabiting the Department of Casanare (Colombia)PLOS NEGLECTED TROPICAL DISEASESIF3.42013-03-0714OAAI
Deficient Regulatory T Cell Activity and Low Frequency of IL-17-Producing T Cells Correlate with the Extent of Cardiomyopathy in Human Chagas' DiseasePLOS NEGLECTED TROPICAL DISEASESIF3.42012-04-2498OAAI
The effects of nitric oxide on the immune response during giardiasisBRAZILIAN JOURNAL OF INFECTIOUS DISEASESIF2.82010-12-0138OA
Nitric oxide donor trans-[RuCl([15]aneN4)NO]2+as a possible therapeutic approach for Chagas' diseaseBRITISH JOURNAL OF PHARMACOLOGYIF7.72010-04-2647OAAI
Recognition by toll-like receptor 2 induces antigen-presenting cell activation and Th1 programming during infection by Neospora caninumIMMUNOLOGY AND CELL BIOLOGYIF32010-04-2049PREAI
IL-17 Produced during Trypanosoma cruzi Infection Plays a Central Role in Regulating Parasite-Induced MyocarditisPLOS NEGLECTED TROPICAL DISEASESIF3.42010-02-16127OAAI
Cutting Edge: Nucleotide-Binding Oligomerization Domain 1-Dependent Responses Account for Murine Resistance against Trypanosoma cruzi InfectionJOURNAL OF IMMUNOLOGYIF3.42009-12-30101OAAI
Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacyJOURNAL OF MEDICINAL CHEMISTRYIF6.82008-06-2163PREAI
Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infectionJOURNAL OF INFECTIOUS DISEASESIF4.52008-05-1579OAAI
Activity of the a new ruthenium NO donor against Trypanosoma cruzi:: trans[RuCl([15]aneN4)NO]2+NITRIC OXIDE-BIOLOGY AND CHEMISTRYIF3.22008-01-010PREAI